Overview

Ed is Professor of Health Economics and Health Policy, and director of the Peninsula Technology Assessment Group (PenTAG), one of 11 research units in the UK providing expert advice on the effects and costs of new drugs to the National Institute of Health and Care Excellence (NICE).

He trained in economics and then health economics at the University of York and holds a PhD in Health Economics from the University of East Anglia.  He has worked at the Universities of York, Cambridge and East Anglia, as well as some time in industry and has expertise in decision analytic modelling and economic evaluation alongside clinical trials.  Ed has applied these in a variety of disease areas including diabetes, stroke, dementia, Asperger’s syndrome, asthma, alcohol misuse, lupus, IVF, pregnancy and childbirth, erectile dysfunction, obesity, physical inactivity, essential thrombocythaemia, actinic keratosis, prostate cancer, renal cancer, melanoma, ulcerative colitis, cholecystitis, carpal tunnel syndrome and idiopathic pulmonary fibrosis.

His methodological research is in the area of efficient research design, specifically value of information analysis, a quantitative approach to setting research priorities making use of uncertainty in the results of economic evaluations to quantify the expected return on investment in further research.